BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schildberg CW, Croner R, Schellerer V, Haupt W, Schildberg FW, Schildberg M, Hohenberger W, Horbach T. Differences in the treatment of young gastric cancer patients: patients under 50 years have better 5-year survival than older patients. Adv Med Sci. 2012;57:259-265. [PMID: 23314560 DOI: 10.2478/v10039-012-0052-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen CQ, Wu XJ, Yu Z, Bu ZD, Zuo KQ, Li ZY, Ji JF. Prognosis of patients with gastric cancer and solitary lymph node metastasis. World J Gastroenterol 2013; 19(46): 8611-8618 [PMID: 24379578 DOI: 10.3748/wjg.v19.i46.8611] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Strong VE, Russo A, Yoon SS, Brennan MF, Coit DG, Zheng C, Li P, Huang C. Comparison of Young Patients with Gastric Cancer in the United States and China. Ann Surg Oncol 2017;24:3964-71. [DOI: 10.1245/s10434-017-6073-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhao X, Xu L, Zheng L, Yin L, Qi Y, Han X, Xu Y, Peng J. Potent effects of dioscin against gastric cancer in vitro and in vivo. Phytomedicine 2016;23:274-82. [PMID: 26969381 DOI: 10.1016/j.phymed.2016.01.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
4 Gong X, Zhang H. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer. J Clin Lab Anal 2020;34:e23268. [PMID: 32118318 DOI: 10.1002/jcla.23268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bozkaya Y, Özdemir NY, Yazıcı O, Demirci NS, Kurtipek A, Erdem GU, Ergün Y, Zengin N. A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer. Asian Pac J Cancer Prev 2018;19:283-90. [PMID: 29374414 DOI: 10.22034/APJCP.2018.19.1.283] [Reference Citation Analysis]
6 Pisanu A, Podda M, Cois A, Uccheddu A. Gastric cancer in the young: is it a different clinical entity? A retrospective cohort study. Gastroenterol Res Pract 2014;2014:125038. [PMID: 24688534 DOI: 10.1155/2014/125038] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
7 Schildberg CW, Abba M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, Croner R, Leupold JH, Hohenberger W, Allgayer H. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations. Adv Med Sci 2014;59:142-6. [PMID: 24797991 DOI: 10.1016/j.advms.2014.03.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
8 Takatsu Y, Hiki N, Nunobe S, Ohashi M, Honda M, Yamaguchi T, Nakajima T, Sano T. Clinicopathological features of gastric cancer in young patients. Gastric Cancer. 2016;19:472-478. [PMID: 25752270 DOI: 10.1007/s10120-015-0484-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
9 Ramos MFKP, Pereira MA, Sagae VMT, Mester M, Morrell ALG, Dias AR, Zilberstein B, Ribeiro Junior U, Cecconello I. Gastric cancer in young adults: a worse prognosis group? Rev Col Bras Cir 2019;46:e20192256. [PMID: 31576989 DOI: 10.1590/0100-6991e-20192256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Schildberg CW, Weidinger T, Hohenberger W, Wein A, Langheinrich M, Neurath M, Boxberger F. Metastatic adenocarcinomas of the stomach or esophagogastric junction (UICC stage IV) are not always a palliative situation: a retrospective analysis. World J Surg. 2014;38:419-425. [PMID: 24146196 DOI: 10.1007/s00268-013-2293-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Schildberg C, Abbas M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, Croner R, Leupolt J, Hohenberger W, Allgayer H. COX-2, TFF1, and Src define better prognosis in young patients with gastric cancer. J Surg Oncol. 2013;108:409-413. [PMID: 24037722 DOI: 10.1002/jso.23416] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]